Guggenheim Maintains Buy on Illumina, Raises Price Target to $305

Guggenheim analyst Subbu Nambi has maintained a Buy rating on Illumina (NASDAQ: ILMN) and raised the price target from $226 to $305. This adjustment reflects a positive outlook for the company in the market.